Pharmacological and Gene modification-based models for studying the impact of perinatal metabolic disturbances in adult life

Advances in Experimental Medicine and Biology

Volumn 646, Issue , 2009, Pages 141-148

  Villarroya, Francesc ^a,b   Bocos, Carlos ^c   Giralt, Marta ^a,b   Ramos, Maria Pilar ^c   Herrera, Emilio ^c   Sevillano, Julio ^c   Gual, Margalida ^a,b   Rosell, Meritxell ^a,b   Iglesias, Roser ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c UNIVERSIDAD SAN PABLO CEU   (Spain)

Author keywords

Fatty acid; Fetus; Insulin sensitivity; Neonate; Peroxisome proliferatoractivated receptor; Thiazolidinedione

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE; ENGLITAZONE; GLITAZONE DERIVATIVE; LIVER RECEPTOR HOMOLOG 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PYRUVATE DEHYDROGENASE KINASE 4; UNCOUPLING PROTEIN 2; UNCOUPLING PROTEIN 3;

ADIPOGENESIS; BROWN ADIPOSE TISSUE; CELL DIFFERENTIATION; CONFERENCE PAPER; DNA MODIFICATION; FATTY ACID OXIDATION; FOOD INTAKE; GENE DISRUPTION; GLUCONEOGENESIS; GLYCOGENOLYSIS; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTERVENTION STUDY; KETOGENESIS; LACTATION; LIPOLYSIS; METABOLIC DISORDER; MILK; NEWBORN DISEASE; NONHUMAN; PERINATAL PERIOD; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM; THERMOGENESIS; TRANSCRIPTION REGULATION; WHITE ADIPOSE TISSUE; ANIMAL; DISEASE MODEL; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MATERNAL NUTRITION; METABOLISM; MOUSE; MOUSE MUTANT; NEWBORN; RAT; REVIEW;

RODENTIA;

ADIPOSE TISSUE, BROWN; ANIMALS; ANIMALS, NEWBORN; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; METABOLIC DISEASES; MICE; MICE, KNOCKOUT; MILK; PPAR ALPHA; PREGNANCY; RATS;

EID: 70349257642     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4020-9173-5_16     Document Type: Conference Paper

References (13)

1. Barbera MJ, Schluter A, Pedraza N, Iglesias R, Villarroya F, Giralt M (2001). Peroxisome proliferator-activated receptor alpha activates transcription of the brown fat uncoupling protein-1 gene. A link between regulation of the thermogenic and lipid oxidation pathways in the brown fat cell. J Biol Chem 276(2):1486-1493. (Pubitemid 32096582)
2. Brun S, Carmona MC, Mampel T, Vinas O, Giralt M, Iglesias R, Villarroya F (1999). Activators of peroxisome proliferator-activated receptor-alpha induce the expression of the uncoupling protein-3 gene in skeletal muscle: a potential mechanism for the lipid intake-dependent activation of uncoupling protein-3 gene expression at birth. Diabetes 48(6):1217-1222. (Pubitemid 29241017)
3. Finck BN, Bernal-Mizrachi C, Han DH, Coleman T, Sambandam N, LaRiviere LL, Holloszy JO, Semenkovich CF, Kelly DP (2005). A potential link between muscle peroxisome proliferatoractivated receptor-alpha signaling and obesity-related diabetes. Cell Metab 1(2):133-144. (Pubitemid 43960595)
4. Guri AJ, Hontecillas R, Bassaganya-Riera J (2006). Peroxisome proliferator-activated receptors: bridging metabolic syndrome with molecular nutrition. Clin Nutr 25(6):871-885. (Pubitemid 44743162)
5. Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W (1999). Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest 103(11):1489-1498.
6. Leone TC, Weinheimer CJ, Kelly DP (1999). A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci USA 96(13):7473-7478. (Pubitemid 29299686)
7. Muoio DM, MacLean PS, Lang DB, Li S, Houmard JA, Way JM, Winegar DA, Corton JC, Dohm GL, Kraus WE (2002). Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knockout mice. Evidence for compensatory regulation by PPAR delta. J Biol Chem 277(29):26089-26097. (Pubitemid 34967092)
8. Murray AJ, Panagia M, Hauton D, Gibbons GF, Clarke K (2005). Plasma free fatty acids and peroxisome proliferator-activated receptor alpha in the control of myocardial uncoupling protein levels. Diabetes 54(12):3496-3502. (Pubitemid 43334341)
9. O'Moore-Sullivan TM, Prins JB (2002). Thiazolidinediones and type 2 diabetes: new drugs for an old disease. Med J Aust 176(8):381-386. (Pubitemid 34436149)
10. Pedraza N, Rosell M, Villarroya J, Iglesias R, Gonzalez FJ, Solanes G, Villarroya F (2006). Developmental and tissue-specific involvement of peroxisome proliferator-activated receptoralpha in the control of mouse uncoupling protein-3 gene expression. Endocrinology 147(10):4695-4704. (Pubitemid 44402177)
11. Sevillano J, Lopez-Perez IC, Herrera E, Del Pilar Ramos M, Bocos C (2005). Englitazone administration to late pregnant rats produces delayed body growth and insulin resistance in their fetuses and neonates. Biochem J 389(Pt 3):913-918. (Pubitemid 41121990)
12. Yang Q, Kurotani R, Yamada A, Kimura S, Gonzalez FJ (2006). Peroxisome proliferator-activated receptor alpha activation during pregnancy severely impairs mammary lobuloalveolar development in mice. Endocrinology 147(10):4772-4780. (Pubitemid 44402184)
13. Yubero P, Hondares E, Carmona MC, Rossell M, Gonzalez FJ, Iglesias R, Giralt M, Villarroya F (2004). The developmental regulation of peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression in the liver is partially dissociated from the control of gluconeogenesis and lipid catabolism. Endocrinology 145(9):4268-4277. (Pubitemid 39120576)